Ignite Creation Date:
2024-05-06 @ 8:18 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06336343
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
2024-03-21
Brief Title:
Bimekizumab in Plaque Psoriasis
Sponsor:
Icahn School of Medicine at Mount Sinai
Organization:
Icahn School of Medicine at Mount Sinai
Organization Data
Organization:
Icahn School of Medicine at Mount Sinai
Class:
OTHER
Study ID:
STUDY-23-01698
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Lead Sponsor Class:
OTHER
Responsible Party:
Mark Lebwohl
Responsible Party Title:
Dean for Clinical Therapeutics Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Icahn School of Medicine at Mount Sinai
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Psoriasis Treatment Center of Central New Jersey | OTHER |
| UCB Pharma | INDUSTRY |